Skip to search formSkip to main contentSkip to account menu

microcin B17

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Fluoroquinolones are very important drugs in the clinical antibacterial arsenal; their success is principally due to their mode… 
2011
2011
The total synthesis of the 43 amino acid antibacterial peptide Microcin B17 (MccB17) is described. The natural product was… 
2003
2003
We have examined the effects of the bacterial toxin microcin B17 (MccB17) on the reactions of Escherichia coli DNA gyrase. MccB17… 
2001
2001
Microcin B17 (MccB17) is a 3.1-kDa Escherichia coli antibiotic that contains thiazole and oxazole heterocycles in a peptide… 
Highly Cited
1999
Highly Cited
1999
In the maturation of the Escherichia coli antibiotic Microcin B17 (MccB17), the McbA prepro-antibiotic is modified post… 
Highly Cited
1997
Highly Cited
1997
Production of the antibacterial polypeptide microcin B17 (MccB17) by Escherichia coli ZK650 was inhibited by simulated… 
Highly Cited
1995
Highly Cited
1995
Microcin B17 (McB17), the first known gyrase inhibitor of peptidic nature, is produced by ribosomal synthesis and post… 
Highly Cited
1994
Highly Cited
1994
Drugs that inhibit the activity of DNA gyrase fall almost exclusively into two structural classes, the quinolones and the… 
Highly Cited
1993
Highly Cited
1993
The maturation pathway of microcin B17 (MccB17), a ribosomally synthesized peptide antibiotic which inhibits DNA gyrase, has been… 
Highly Cited
1985
Highly Cited
1985
The production of the antibiotic substance microcin B17 (Mcc) is determined by a 3.5-kilobase DNA fragment from plasmid pMccB17…